Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Méndez (Valencia, Spain), A. Moscardó (Valencia, Spain), A. Latorre (Valencia, Spain), A. Piró (Valencia, Spain), I. Amara-Elori (Valencia, Spain), A. Gimeno (Valencia, Spain), P. González (Valencia, Spain), L. Feced (Valencia, Spain), M. Climent (Valencia, Spain), R. Menéndez (Valencia, Spain). Platelet activation is boosted early in community-acquired pneumonia and sustained until 30 days later. 2633

Member's Comments

No comment yet.

Related content which might interest you: Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection Source: Eur Respir J, 56 (2) 2001754; 10.1183/13993003.01754-2020 Year: 2020 A delay in reaching time to clinical stability (tcs) for hospitalized patients with community-acquired pneumonia (CAP) is associated with failure within 30 days after hospital discharge Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Platelet count as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Community acquired pneumonia (CAP) 30 days mortality and biomarkers Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 Discharge delay in patients with community-acquired pneumonia (CAP) treated with a pneumonia critical pathway Source: Eur Respir J 2002; 20: Suppl. 38, 560s Year: 2002 Pre-24 hours hospital lethality of patients with community-acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004 Is it necessary to follow up for one week after the end of antibiotic therapy in community-acquired pneumonia? Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002 An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis Source: Eur Respir Rev, 29 (157) 200240; 10.1183/16000617.0240-2020 Year: 2020 Macrophage activation in exacerbated COPD with and without community-acquired pneumonia Source: Eur Respir J 2010; 36: 285 Year: 2010 Impact of neutrophil apoptosis on clinical outcomes in nonresponding community-acquired pneumonia Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Correlation between pneumonia severity index and mortality within 30 days after the diagnosis of community-acquired pneumonia in elderly subjects Source: Eur Respir J 2006; 28: Suppl. 50, 741s Year: 2006 Profile of selected cytokines in serum and in BAL-fluid in patients with cryptogenic organising pneumonia before and after 3 months of calrithromycin treatment Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Effect of benzylpenicillin-ciprofloxacin vs. ceftriaxon-ciprofloxacin in treatment of massive pneumonia (CAP-community acquired pneumonia) Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Disseminated bacterial community-acquired pneumonia in patients at late stages of HIV infection Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 7-day course of antibiotics had similar efficacy to prolonged course in severe community-acquired pneumonia: a propensity-adjusted analysis Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Impact of neutrophil function on outcomes of community-acquired pneumonia (CAP) in patients with cancer Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007